Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes

Fig. 3

Primary endpoint and myocardial salvage index. Cumulative incidence of MACE in the groups on therapy with SGLT-2i (ref), GLP-1RA, and their combination with the relative hazard ratios (HR) and confidence intervals (CI) resulting from the relative Cox regression analysis (A); percentange of myocardial salvage index assessed thorugh SPECT after 3 months in the three groups (B). *P < 0.05 SGLT-2i/GLP-1RA vs SGLT-2i; †P < 0.05 SGLT-2i/GLP-1RA vs GLP-1RA; Kruskal–Wallis followed by Dunn’s test. Boxplots show the median, 25th, and 75th percentiles, range, and extreme values

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840